![]() |
|
|
Vol. 289, Issue 3, 1654-1661, June 1999
Department of Cell Biology and Histology, Sackler School of
Medicine, Tel Aviv University, Tel Aviv, Israel (I.S., R.S.-E.); and
Department of Biological Regulation, The Weizmann Institute of Science,
Rehovot, Israel (R.S.)
The family of basic secretagogues of connective tissue mast cells act
as receptor mimetic agents, which trigger exocytosis by directly
activating G proteins. We now demonstrate that pertussis toxin
(Ptx)-sensitive Gi proteins, activated by compound 48/80 (c48/80), a
potent member of this family, also activate the p42/p44 MAP kinases
(MAPKs). This activation was potentiated by the protein tyrosine
phosphatase inhibitor vanadate, whereas the tyrphostin AG-18, a
competitive inhibitor of protein tyrosine kinases (PTKs); the protein
kinase C inhibitors K252a and GF109203X; the
phosphatidylinositol-3-kinase (PI-3K) inhibitors wortmannin and
LY294002; and EGTA have abolished this activation. These results
suggest that c48/80 activated the p42/p44 MAPKs via a mechanism that
involves PTKs, protein kinase C, phosphatidylinositol-3-kinase and
Ca2+ as mediators. Protein tyrosine phosphorylation and
activation of the p42/p44 MAPKs were closely correlated with
stimulation of arachidonic acid (AA) release by c48/80 but not with
histamine secretion. However, whereas PD98059, the inhibitor of the
MAPK kinase has abrogated MAPK activation, this inhibitor failed to effect release of AA. We therefore conclude that by activating Ptx-sensitive Gi protein(s), the basic secretagogues of mast cells stimulate multiple signaling pathways, which diverge to regulate the
production and release of the different inflammatory mediators. Whereas
the signaling pathway responsible for triggering histamine release is
PTK independent, the pathway responsible for the stimulation of AA
release bifurcates downstream to PTKs but upstream to the activation of MAPKs.
This article has been cited by other articles:
![]() |
M. M. Ibrahim, F. Porreca, J. Lai, P. J. Albrecht, F. L. Rice, A. Khodorova, G. Davar, A. Makriyannis, T. W. Vanderah, H. P. Mata, et al. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids PNAS, February 22, 2005; 102(8): 3093 - 3098. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Piliponsky, G. J. Gleich, A. Nagler, I. Bar, and F. Levi-Schaffer Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor Blood, March 1, 2003; 101(5): 1898 - 1904. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ferry, V. Eichwald, L. Daeffler, and Y. Landry Activation of {beta}{gamma} Subunits of Gi2 and Gi3 Proteins by Basic Secretagogues Induces Exocytosis Through Phospholipase C{beta} and Arachidonate Release Through Phospholipase C{gamma} in Mast Cells J. Immunol., November 1, 2001; 167(9): 4805 - 4813. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Shefler and R. Sagi-Eisenberg Gi-Mediated Activation of the Syk Kinase by the Receptor Mimetic Basic Secretagogues of Mast Cells: Role in Mediating Arachidonic Acid/Metabolites Release J. Immunol., July 1, 2001; 167(1): 475 - 481. [Abstract] [Full Text] [PDF] |
||||